Menu Search
Equities

Sonendo Inc

SONX:QXR

Sonendo Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.0344
  • Today's Change0.000 / -0.29%
  • Shares traded95.75k
  • 1 Year change-95.81%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 18:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Sonendo Inc had net income fall 6.78% from a loss of 57.05m to a larger loss of 60.92m despite a 5.30% increase in revenues from 41.66m to 43.87m.
Gross margin35.04%
Net profit margin-126.79%
Operating margin-114.56%
Return on assets-63.14%
Return on equity-133.95%
Return on investment-78.26%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Sonendo Inc fell by 3.66m. However, Cash Flow from Investing totalled 42.40m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 46.06m for operations while cash generated from financing totalled 4.00k.
Cash flow per share-0.4907
Price/Cash flow per share--
Book value per share0.2453
Tangible book value per share0.2453
More ▼

Balance sheet in USDView more

Sonendo Inc has a Debt to Total Capital ratio of 51.94%, a lower figure than the previous year's 69.83%.
Current ratio2.40
Quick ratio1.73
Total debt/total equity1.08
Total debt/total capital0.5194
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.